Appili Therapeutics Inc. (APLIF)
Develops antibiotics and vaccines targeting neglected infectious diseases.
$0.01+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+0.0%
The outlook
APLIF is trading near its 52-week lows, sitting well below both its 50- and 200-day moving averages. Analyst coverage appears minimal, and the current data reflects a heavily bearish lean overall. The stock's position at the lower end of its annual range suggests sustained downward pressure.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range13% of the way from its 52-week low to high
Market cap
$1.5M
52-wk high
$0.03
52-wk low
$0.01
50-day avg
$0.01
200-day avg
$0.01
Trailing P/E
—